Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001079973-26-000008

Chief Financial Officer sold 247 shares at $3.56 ($879)

From the SEC's structured data for this filing

Trades in this filing

Carter Robert Ross · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Sale : show line 1 in the form −247 $3.56 $879 235,122 D
Open-market sales · 247 sh · avg $3.56 · $879
Loading xslF345X05/ownership.xml…